Abstract
Summary:
Cancer vaccine development has been historically fraught with difficulty, but tremendous progress has been made over the past 5 years. In this In Focus article, we reflect on the progress and challenges with vaccine development for cancers in general and for hematologic malignancies in particular, and suggest how our cancer vaccine experience can offer insight into COVID-19 vaccination.
©2020 American Association for Cancer Research.
2020
American Association for Cancer Research.
You do not currently have access to this content.